Welcome to our dedicated page for Ekso Bionics Holdings news (Ticker: EKSO), a resource for investors and traders seeking the latest updates and insights on Ekso Bionics Holdings stock.
Ekso Bionics Holdings, Inc. (Symbol: EKSO) is a pioneering company in the field of robotic exoskeletons, or wearable robots, aimed at augmenting human strength, endurance, and mobility. Since its founding in 2005, Ekso Bionics has developed cutting-edge technology that has enabled thousands of people with paralysis to take millions of steps that would otherwise be impossible. Headquartered in Richmond, California, with international offices in London, the company has been a leader in both the healthcare and industrial markets.
Ekso Bionics operates through two main segments: EksoHealth and EksoWorks. The EksoHealth segment, which generates the majority of the company's revenue, focuses on designing, engineering, manufacturing, and selling exoskeletons for medical applications. These devices are worn over clothing and controlled by trained operators to assist individuals with mobility challenges. The EksoWorks segment, on the other hand, targets able-bodied users by creating exoskeleton devices that help them perform strenuous, repetitive tasks for extended periods.
Over the years, Ekso Bionics has been at the forefront of innovation, continuously pushing the boundaries of what robotic exoskeletons can achieve. Their products have not only redefined the scope of physical rehabilitation but have also found significant applications in various industrial settings, allowing workers to carry out challenging tasks more efficiently. Ekso Bionics is committed to breaking physical limitations and helping users reach new heights of capability.
For the latest updates, partnerships, and developments related to Ekso Bionics and their stock performance, visit StockTitan regularly.
Ekso Bionics Holdings (Nasdaq: EKSO) will announce its financial and business results for Q1 2023 on April 27, 2023. The release will take place after the close of trading, followed by a conference call at 1:30 PM PT / 4:30 PM ET to discuss the results and recent developments. A live webcast will be available on the Company’s website, providing investors with real-time insights. This call presents an opportunity for stakeholders to engage with management regarding the company’s performance in the exoskeleton technology sector, which serves both medical and industrial markets. The replay of the call will also be accessible for one month post-event.
Ekso Bionics (Nasdaq: EKSO) has announced a significant collaboration with SoldierStrong, a non-profit focused on improving Veterans' lives through technology. SoldierStrong will donate an Ekso Indego Therapy device to the Spinal Cord Injury Unit at Augusta's Charlie Norwood VA Medical Center. This donation marks the 30th exoskeleton provided by SoldierStrong over the last decade, reaffirming their commitment to Veterans. The device is designed for individuals with spinal injuries and stroke, enabling them to stand and walk. A donation ceremony is scheduled for April 26, 2023, featuring a demonstration of the device, further emphasizing its clinical benefits. This partnership aims to deliver critical rehabilitation support, enhancing mobility for Veterans.
FAQ
What is the current stock price of Ekso Bionics Holdings (EKSO)?
What is the market cap of Ekso Bionics Holdings (EKSO)?
What does Ekso Bionics Holdings, Inc. do?
Where is Ekso Bionics headquartered?
What are the main segments of Ekso Bionics?
What does the EksoHealth segment specialize in?
What does the EksoWorks segment focus on?
How has Ekso Bionics impacted people with paralysis?
In which regions does Ekso Bionics operate?
How can I get in touch with Ekso Bionics for investor relations?
What innovations has Ekso Bionics brought to the industrial market?
How does Ekso Bionics contribute to physical rehabilitation?
